Refer a patient for screening and trials

Dementia trials are slow and expensive compared to other disease conditions. Despite the high number of persons developing Alzheimer’s disease each year, on average a clinical trial site only recruits 8-10 participants per year for a particular trial. Among those referred to a trial, most fail the strict inclusion/exclusion criteria.

Access free diagnostic assessment for your patient

By referring your patient to the Australian Dementia Network Screening and Trials program, your patient will undergo a comprehensive free diagnostic assessment using techniques that are not routinely available, such as PET amyloid and tau brain scans. With these methods, Alzheimer’s disease can be detected up to 15 years before symptoms become evident (“preclinical AD”).

Results from the assessments are provided to the referring doctor, along with tailored trial recommendations.

We currently have screening sites operating in Melbourne, Adelaide, Sydney, Newcastle, Brisbane and Perth.

Contact

To refer your patient: please complete the referral form below, otherwise; please contact Dr Jo Robertson – Australian Dementia Network Screening and Trials Coordinator, complete our contact form, or download a copy of your local referral form.

ADNeT Screening information and local contacts

Refer a patient now

Prior Investigations
Please tick if previously completed:
Amyloid PET Feedback
Amyloid PET result to be disclosed by:
Further Investigations
Arrange an expedited brain SPECT & FDG PET if amyloid or tau imaging are negative?
Please provide patient details:
DD slash MM slash YYYY
Drop files here or
Max. file size: 128 MB.

    Download a copy of your local referral form for future use

    Eligibility Guide

    • Probable MCI or mild AD
    • Fluent in English
    • Aged ≥ 50 years
    • MMSE score ≥ 20
    • Reliable study partner/informant available
    • Able to tolerate neuropsychological assessment
    • Formal education of ≥7 years
    • No serious unstable comorbid conditions